Western blot analysis demonstrated that Ac-Gb4 treatment induces FAK cleavage, reduces AKT expression, and activates caspase-3, establishing the molecular mechanism for decreased cancer cell invasion and survival. This evidence concerns the gene AKT1 and cancer.